Loss Of Exclusivity Product Launches To Fuel Aurobindo’s FY26 Europe Growth

FY28 Inflection Point For Biosimilars

Europe Seems Like A Lighthouse In The Rough Seas Of Business Uncertainty
Aurobindo Seeks Safety On Europe's Shores Amid Fog In The US (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Leadership